ADARE PHARMA SOLUTIONS
LIVE

Serial Number

90364102

Owner

Adare Pharmaceuticals, Inc.

Attorney

Shawn Duckworth

First Use Date

Oct 2, 2020

Filing Date

Dec 7, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ADARE PHARMA SOLUTIONS Trademark

Serial Number: 90364102 • Registration: 6669722

ADARE PHARMA SOLUTIONS is a trademark filed by Adare Pharmaceuticals, Inc. on December 7, 2020. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Adare Pharmaceuticals, Inc. (8 trademarks)

7722 Dungan Road
Philadelphia, PA 19111

Entity Type: 03

Trademark Details

Filing Date

December 7, 2020

Registration Date

March 15, 2022

First Use Anywhere

October 2, 2020

First Use in Commerce

October 2, 2020

Published for Opposition

December 28, 2021

Goods & Services

Manufacturing of pharmaceutical and nutritional and dietary formulations, to the specifications of others, used as facilitating agents for tablets, capsules, powders, injectables, suspensions, gels, liquids; Manufacturing services for others of drug delivery products for the immediate, controlled, extended, delayed, pulsatile or local release of a therapeutic, nutritional or dietary agent; Manufacturing services for others of pharmaceutical and dietary compositions for use in veterinary administration forms such as tablets, capsules, suspensions, liquids; Manufacturing services for others of particles with specific particle dimension and narrow particle size distributions containing active ingredients

Design and development of pharmaceutical, nutritional and dietary formulations; Research and development of drug delivery formulation used as facilitating agents for pharmaceutical tablets, capsules, powders, injectables, suspensions, gels, liquids; Development of pharmaceutical formulations for veterinary applications; Design and development of preparations in liquid form or solid form for the immediate, controlled, extended, delayed, pulsatile or local release of a therapeutic or dietary agent; Development of particles with defined particle size dimensions and particle size distribution containing active ingredients for pharmaceutical purposes; Technology consultation in the field of pharmaceutical development

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 20, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 20, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 20, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 20, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 20, 2025 COAR
REGISTERED-PRINCIPAL REGISTER
Mar 15, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 28, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 28, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 8, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 23, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 19, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 18, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 18, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 26, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 26, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 26, 2021 CNRT
ASSIGNED TO EXAMINER
May 25, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 13, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2021 NWOS
NEW APPLICATION ENTERED
Dec 10, 2020 NWAP